Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

VolumeIssuePage

Issues

Flow-cytometric immunophenotyping of normal and malignant lymphocytes

Tomasz Szczepański1 / Vincent H.J. van der Velden2 / Jacques J.M. van Dongen3

1.

2.

3.

Corresponding author: Prof. J.J.M. van Dongen, MD, PhD, Department of Immunology, Erasmus MC, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands Phone: +31-10-4088094, Fax: +31-10-4089456,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 44, Issue 7, Pages 775–796, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2006.146, June 2006

Publication History

Received:
February 14, 2006
Accepted:
March 17, 2006
Published Online:
2006-06-16

Abstract

During the past two decades, flow-cytometric immunophenotyping of lymphocytes has evolved from a research technique into a routine laboratory diagnostic test. Extensive studies in healthy individuals resulted in detailed age-related reference values for different lymphocyte subpopulations in peripheral blood. This is an important tool for the diagnosis of hematological and immunological disorders. Similar, albeit less detailed, information is now available for other lymphoid organs, e.g., normal bone marrow, lymph nodes, tonsils, thymus and spleen. Flow-cytometric immunophenotyping forms the basis of modern classification of acute and chronic leukemias and is increasingly applied for initial diagnostic work-up of non-Hodgkin's lymphomas. Finally, with multiparameter flow cytometry, it is now possible to identify routinely and reliably low numbers of leukemia and lymphoma cells (minimal residual disease).

Clin Chem Lab Med 2006;44:775–96.

Keywords: bone marrow; CD markers; flow cytometry; leukemias; lymph node; lymphocyte; lymphomas; minimal residual disease; peripheral blood

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Fatemeh Salari, Mohammad Shahjahani, Saeid Shahrabi, and Najmaldin Saki
Medical Oncology, 2014, Volume 31, Number 11
[2]
Maria Szczepańska, Joanna Bulsa, Łukasz Sędek, Aurelia Morawiec-Knysak, Alicja Sonsala, Bogdan Mazur, Jacek Karpe, Katarzyna Ziora, and Tomasz Szczepański
Pediatria Polska, 2013, Volume 88, Number 6, Page 500
[3]
Carlos E. Pedreira, Elaine S. Costa, Quentin Lecrevisse, Jacques J.M. van Dongen, and Alberto Orfao
Trends in Biotechnology, 2013, Volume 31, Number 7, Page 415
[4]
Barbara Piątosa, Mariusz Birbach, Katarzyna Siewiera, Marek Ussowicz, Krzysztof Kałwak, Katarzyna Drabko, Aneta Rękawek, Katarzyna Tkaczyk, and Przemysław Norbert Kurowski
Cytometry Part B: Clinical Cytometry, 2013, Volume 84B, Number 3, Page 179
[5]
Bella Patel and Letizia Foroni
Clinical Leukemia, 2006, Volume 1, Number 2, Page 108
[7]
Alexa E. Joetzke, Nina Eberle, Ingo Nolte, Reinhard Mischke, and Daniela Simon
American Journal of Veterinary Research, 2012, Volume 73, Number 6, Page 884
[8]
[9]
Maria Szczepańka, Joanna Bulsa, Łukasz Sędek, Aurelia Morawiec-Knysak, Alicja Sonsala, Bogdan Mazur, Jacek Karpe, Katarzyna Ziora, and Tomasz Szczepański
Pediatria Polska, 2012, Volume 87, Number 2, Page 154
[10]
P. Rhein, R. Mitlohner, G. Basso, G. Gaipa, M. N. Dworzak, R. Kirschner-Schwabe, C. Hagemeier, M. Stanulla, M. Schrappe, W.-D. Ludwig, L. Karawajew, and R. Ratei
Blood, 2010, Volume 115, Number 18, Page 3763
[11]
R. van Gent, C.M. van Tilburg, E.E. Nibbelke, S.A. Otto, J.F. Gaiser, P.L. Janssens-Korpela, E.A.M. Sanders, J.A.M. Borghans, N.M. Wulffraat, M.B. Bierings, A.C. Bloem, and K. Tesselaar
Clinical Immunology, 2009, Volume 133, Number 1, Page 95
[12]
Maria Szczepańska, Joanna Bulsa, Łukasz Sędek, Ewa Muszewska, Aurelia Morawiec-Knysak, Aleksander Matyl, Alicja Sonsala, Bogdan Mazur, Jacek Karpe, and Tomasz Szczepański
Pediatria Polska, 2011, Volume 86, Number 2, Page 123
[13]
Jarosław Szarek, Łukasz Sędek, Tomasz Hajzler, Danuta Sońta-Jakimczyk, Bogdan Mazur, and Tomasz Szczepański
Pediatria Polska, 2007, Volume 82, Number 9, Page 713
[14]
Sabrina Uhrmacher, Felix Erdfelder, and Karl-Anton Kreuzer
Advances in Hematology, 2010, Volume 2010, Page 1
[15]
C. Thomas Nebe, Herrad Baurmann, Gudrun Kuling, and Heinz Diem
LaboratoriumsMedizin, 2008, Volume 32, Number 6, Page -
[16]
R. A. Brooimans, J. Kraan, W. van Putten, J. J. Cornelissen, B. Löwenberg, and J. W. Gratama
Cytometry Part B: Clinical Cytometry, 2009, Volume 76B, Number 1, Page 18
[17]
Marta Steinbrich-Zöllner, Joachim R. Grün, Toralf Kaiser, Robert Biesen, Katharina Raba, Peihua Wu, Andreas Thiel, Martin Rudwaleit, Joachim Sieper, Gerd-Rüdiger Burmester, Andreas Radbruch, and Andreas Grützkau
Cytometry Part A, 2008, Volume 73A, Number 4, Page 333

Comments (0)

Please log in or register to comment.